Sample size The semaglutide study included eight mothers
For current pricing on compounded retatrutide, see our [cost guide](/guides/retatrutide-cost-price-guide-2026)
The 12 week phase 1b clinical trial for patients with type 2 diabetes from December 18, 2018 to December 28, 2020 showed that the three high-dose groups of Retatrutide were significantly better than the placebo control group in reducing blood sugar and glycosylated hemoglobin (HbA1c), and showed a dose related weight loss effect
The reason lies in the digestive systems hostility toward these molecules on multiple levels: Palatability: Peptides like semaglutide cause a distinct bitterness
According to the American Diabetes Association , studies comparing GLP-1 medications have demonstrated significant weight loss potential for both semaglutide and tirzepatide
That is an enormous number, and it is why tirzepatide is still the standard every newer weight-loss compound has to beat